What the pulmonary specialist should know about the new inhalation therapies

A collaboration of multidisciplinary experts on the delivery of pharmaceutical aerosols was facilitated by the European Respiratory Society (ERS) and the International Society for Aerosols in Medicine (ISAM), in order to draw up a consensus statement with clear, up-to-date recommendations that enabl...

Full description

Saved in:

Bibliographic Details
Published in:	The European respiratory journal Vol. 37; no. 6; p. 1308
Main Authors:	Laube, B L, Janssens, H M, de Jongh, F H C, Devadason, S G, Dhand, R, Diot, P, Everard, M L, Horvath, I, Navalesi, P, Voshaar, T, Chrystyn, H
Format:	Journal Article
Language:	English
Published:	England 01.06.2011
Subjects:	Acquired Immunodeficiency Syndrome - drug therapy Administration, Inhalation Advisory Committees - standards Aged Aged, 80 and over Asthma - drug therapy Child Child, Preschool Cystic Fibrosis - drug therapy Familial Primary Pulmonary Hypertension Humans Hypertension, Pulmonary - drug therapy Lung Diseases - drug therapy Nebulizers and Vaporizers Physician-Patient Relations Pulmonary Disease, Chronic Obstructive - drug therapy Pulmonary Medicine - standards Respiration, Artificial - methods Respiratory Therapy - standards
ISSN:	1399-3003, 1399-3003
Online Access:	Get more information
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!